Tech Mahindra has entered into strategic partnership with Kitsa, the AI operating system for clinical trial start-up, to advance agentic AI-driven medical writing solutions for the global pharmaceutical and biotechnology industry. The partnership represents the latest in Kitsa’s growing network of global technology alliances, as the company scales its reach across the pharmaceutical value chain.

The partnership further strengthens Tech Mahindra’s Gen AI Medical Writing offering for Life Sciences by integrating Kitsa’s KScribe platform, enabling pharmaceutical sponsors and CROs to accelerate clinical trial protocol development and regulatory documentation using purpose-built artificial intelligence.

Through this partnership, the company will enhance the go-to-market capabilities to its global pharmaceutical and biotech customer base, helping organizations modernize clinical development workflows at scale.

Tech Mahindra offers technology consulting and digital solutions to global enterprises across industries, enabling transformative scale at unparalleled speed.